DOCETAXEL News

DOCETAXEL currently has 8 news articles, with 24 predicted indications.

This page combines the AI-predicted indications for DOCETAXEL with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Evidence level: L5
Predicted indications (24):
- prostate carcinoma (99.0%)
- prostate cancer (99.0%)
- breast carcinoma (99.0%)
- familial prostate carcinoma (99.0%)
- gastric cancer (99.0%)
- breast neoplasm (99.0%)
- non-small cell lung carcinoma (disease) (99.0%)
- gastric linitis plastica (99.0%)
- head and neck cancer (99.0%)
- upper aerodigestive tract neoplasm (99.0%)
- gastric carcinoma (99.0%)
- diffuse gastric adenocarcinoma (99.0%)
- lung cancer (99.0%)
- gastric neoplasm (99.0%)
- female breast carcinoma (99.9%)
- Ewing sarcoma (99.9%)
- well-differentiated fetal adenocarcinoma of the lung (99.8%)
- small cell lung carcinoma (99.8%)
- primary pulmonary lymphoma (99.8%)
- botryoid-type embryonal rhabdomyosarcoma of the vagina (99.8%)
- pulmonary blastoma (99.8%)
- rhabdomyosarcoma (disease) (99.8%)
- embryonal extrahepatic bile duct rhabdomyosarcoma (99.8%)
- parameningeal embryonal rhabdomyosarcoma (99.8%)